89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft-Reference-Cited by-同舟云学术

89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft

Published:2010-02 Issue:3 Volume:46 Page:678-684
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Oude Munnink Thijs H.,Korte Maarten A. de,Nagengast Wouter B.,Timmer-Bosscha Hetty,Schröder Carolina P.,Jong Johan R. de,Dongen Guus A.M.S. van,Jensen Michael Rugaard,Quadt Cornelia,Hooge Marjolijn N. Lub-de,Vries Elisabeth G.E. de

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress;Workman;Ann NY Acad Sci,2007

2. Unusual expression and localization of heat-shock proteins in human tumor cells;Ferrarini;Int J Cancer,1992

3. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors;Kamal;Nature,2003

4. Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies;Banerji;J Clin Oncol,2005

5. Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study;Modi;J Clin Oncol,2007

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine‐Enabled Mild Photothermal Therapy Strategies for Enhanced Antitumor Treatment;Advanced NanoBiomed Research;2024-01-24

2. Light‐Driven Radiochemistry with Fluorine‐18, Carbon‐11 and Zirconium‐89;Angewandte Chemie International Edition;2024-01-15

3. Light‐Driven Radiochemistry with Fluorine‐18, Carbon‐11 and Zirconium‐89;Angewandte Chemie;2024-01-15

4. La TEP en gynéco-oncologie, au-delà du [18F]FDG ?;Médecine Nucléaire;2023-08

5. Chelating Agents for Zirconium-89 in the Synthesis of Radiopharmaceuticals: Current State and Prospects of Development;Russian Journal of Coordination Chemistry;2022-11